Your SlideShare is downloading. ×
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply



Published on

1 Like
  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Chapter 16Schizophrenia and Affective Disorders
  • 2.  Schizophrenia  Description  Schizophrenia: • A serious mental disorder characterized by: Disordered thoughts Delusions of persecution or grandeur Hallucinations (mostly auditory) Behaviors (withdrawn or detached, odd movements))
  • 3.  Schizophrenia  Description  Positive symptom: (known by their presence) • delusions, hallucinations, abnormal movements, or thought disorders.  Negative symptom: (characterized by absence) • social withdrawal, lack of affect, and reduced motivation.
  • 4.  Schizophrenia  Possible Causes: • Heritability is a statistical concept that estimates the relative contribution of genetic factors to variability in a trait (e.g., schizophrenia). It is not a measure of the amount of contribution (e.g., 60% genes vs 40% environment). • Heritability: In its simplest form, if schizophrenia were determined by a single dominant gene, about 75% of children from schizophrenic parents would get it. If it was recessive, about 50% would inherit the disorder. An incidence less than 50% suggests that the disease is determined by multiple genes and that only a susceptibility is passed on.
  • 5.  Schizophrenia  Evidence for heritability • Concordance rates: Most studies suggest between 25-40% concordance in identical twins and about 5- 20% in fraternal twins. Clearly, the environment is an important contribution.
  • 6.  Schizophrenia  Biochemical Causes • Dopamine Hypothesis: schizophrenia is caused by excessive dopamine activity in the mesolimbic system. • Supporting evidence: drug treatment, amphetamine psychosis, treatment for Parkinson’s disease • Additional evidence: increased DA activity, increased D3 & D4 receptors in mesolimbic system,
  • 7.  Schizophrenia  Pharmacology of Schizophrenia  Chlorpromazine: A phenothiazine • A “typical neuroleptic”; a nonspecific dopamine receptor blocker; first prescribed antischizophrenic drug.  Clozapine: • An “atypical neuroleptic”; an antipsychotic drug that blocks D4 receptors in the nucleus accumbens. Little effect on D2 receptors
  • 8. Copyright © 2004 Allyn and Bacon
  • 9. Copyright © 2004 Allyn and Bacon
  • 10.  Schizophrenia  Consequences of Long-Term Drug Treatment of Schizophrenia  Tardive dyskinesia: • A movement disorder that can occur after prolonged treatment with antipsychotic medication, characterized by involuntary movements of the face and neck.  Supersensitivity: • The increased sensitivity of neurotransmitter receptors; caused by damage to the afferent axons or long-term blockage of neurotransmitter release.
  • 11.  Schizophrenia  Evidence for neurological abnormalities Negative symptoms  Schizophrenics with negative symptoms have similar symptoms as those with fromtal lobe damage. • Frontal lobe size • Ventrical size • Cerebral gray matter decreases
  • 12. Copyright © 2004 Allyn and Bacon
  • 13. Copyright © 2004 Allyn and Bacon
  • 14.  Schizophrenia  Possible Causes of the Brain Abnormalities  Epidemiology: • The study of the distribution and causes of diseases in populations. • Research suggest several environmental factors: -Season of birth: greatest during winter months -Viral epidemics: associated with viral diseases -Latitude: increased incidence further from equator -Prenatal malnutrition: ? -Rh incompatibility: ? -Maternal stress: ?
  • 15. Copyright © 2004 Allyn and Bacon
  • 16. Copyright © 2004 Allyn and Bacon
  • 17. Copyright © 2004 Allyn and Bacon
  • 18. Copyright © 2004 Allyn and Bacon
  • 19.  Schizophrenia  Degenerative process or sudden cell loss? • Woods (1998) found that the cell loss in schizophrenic patients appears to occur suddenly during late adolescence or early adulthood. Schizophrenia is not a gradual degenerative disease like Parkinson’s or Alzheimer’s diseases. • Does not appear to involve cell death and ‘gliosis’ (replacement of neural tissue by glia). • Appears to involve loss of dendrites. Areas of tissue loss are correlated with symptoms (temporal lobes with auditory hallucinations, for example). • The frontal cortex seems to be involved in most cases of schizophrenia (hypofrontality)
  • 20.  Schizophrenia  The cause of schizophrenia now appears to be a disturbance of normal brain development. • Genetic predisposition may make individuals more susceptible • Obstetric complications may cause individuals without genetic predisposition to develop schizophrenia
  • 21.  Schizophrenia  Hypofrontality (caused by a reduction in cell volume in the dorsolateral frontal cortices) is associated with negative symptoms of schizophrenia.  Hypofrontality also results in an increase in dopamine activity in the mesolimbic system which is associated with positive symptoms.  Dopamine hypothesis suggests that hypofrontality results in a disruption of normal glutamate activity from the frontal cortex to the mesolimbic system.  NMDA agonists cannot be used because they would cause seizures, but glycine may be effective in treating schizophrenics since it is also an NMDA agonist. Several studies have shown good results with negative symptoms
  • 22.  Major Affective Disorders  Description  Major affective disorder: • A serious mood disorder; includes major depressive disorder and bipolar disorder. • May effect as many as 5% of US population in a given year. Perhaps as many as 25% over lifetime.
  • 23.  Major Affective Disorders  Description  Major depressive disorder: • A serious mood disorder that consists of unremitting depression or periods of depression that do not alternate with periods of mania.  Bipolar disorder: • A serious mood disorder characterized by cyclical periods of mania and depression.
  • 24.  Major Affective Disorders  Causes of Depression  Genetic contributions: • Bipolar disorder may be caused by a single dominant gene. Location still not confirmed, but heritability studies reveal strong link.  Major depressive disorder: • Less likely caused by single gene than bipolar disorder. • Amine hypothesis: deficiencies in activity of one or several amine neurotransmitter systems (NE, SE)
  • 25.  Major Affective Disorders  Drug Treatment for Depression  Tricyclic antidepressants: • A class of drugs used to treat depression; inhibits the reuptake of norepinephrine and serotonin; named for the specific molecular structure. Amitriptyline (Elavil)  Monoamine oxidase inhibitors (MAOIs): • Prevent degradation of NT in synapse. phenelzine (Nardil)  Serotonin specific reuptake inhibitor (SSRI): • A drug that inhibits the reuptake of serotonin without affecting the reuptake of other neurotransmitters. fluoxetine (Prozac)
  • 26.  Major Affective Disorders  Physiological Treatments  Lithium • A chemical element; lithium carbonate is used to treat bipolar disorder  Carbamazepine: • An anticonvulsive drug (trade name: Tegretol) that is used to treat seizures originating from a focus, also used to treat mania in bipolar disorder.
  • 27. Copyright © 2004 Allyn and Bacon
  • 28.  Major Affective Disorders  Physiological Treatments Electroconvulsive therapy (ECT): • A brief electrical shock that induces a seizure; used therapeutically to alleviate severe depression when medication is not effective. Transcranial Magnetic Stimulation (TMS): Magnetic field causes a weak electrical field and electrical current within the brain. Has been useful in some cases of depression.
  • 29. Copyright © 2004 Allyn and Bacon
  • 30.  Major Affective Disorders  Evidence of Brain Abnormalities  Brain abnormalities: • Research suggests abnormalities in the prefrontal cortex, basal ganglia, hippocampus, thalamus, cerebellum, and temporal lobes. • Some evidence suggests increased size of the cerebral ventricles may suggest the loss of neural tissue.
  • 31.  Major Affective Disorders  Evidence of Brain Abnormalities  Silent cerebral infarction (SCI): • A small cerebrovascular accident (stroke) that causes minor brain damage without producing obvious neurological symptoms.
  • 32.  Major Affective Disorders  Role of Circadian Rhythms  REM Sleep Deprivation: • Selective deprivation of REM sleep through EEG monitoring, is one of the most effective antidepressant treatments; suggests a close relationship between REM sleep and mood. • Antidepressant effects require several weeks of deprivation.
  • 33. Copyright © 2004 Allyn and Bacon
  • 34. Copyright © 2004 Allyn and Bacon
  • 35. Copyright © 2004 Allyn and Bacon
  • 36.  Major Affective Disorders  Role of Circadian Rhythms  Total Sleep Deprivation: • Total sleep deprivation has antidepressant effect that are immediate; however, the procedure is not very practical. • Some individuals do not respond to total or selective sleep deprivation.
  • 37.  Major Affective Disorders  Role of Zeitgebers  Seasonal affective disorder (SAD): • A mood disorder characterized by depression, lethargy, sleep disturbances, and craving for carbohydrates during the winter months.  Summer depression: • A mood disorder characterized by depression, sleep disturbances, and loss of appetite.
  • 38.  Major Affective Disorders  Role of Zeitgebers  Phototherapy: • Treatment of seasonal affective disorder by daily exposure to bright light.